Summary

for males ages 19 years and up (full criteria)
at San Francisco, California
study started
estimated completion
Thomas Hope

Description

Summary

The investigators are imaging patients with prostate cancer using a new PET imaging agent (Ga-68-PSMA-11) in order to evaluate its ability to detect prostate cancer.

Keywords

Prostate Cancer Prostatic Neoplasms Edetic Acid Ga-68 labeled PSMA-11 PET Ga-68 labeled PSMA-11 PET PSMA PET imaging

Eligibility

You can join if…

Open to males ages 19 years and up

  1. Histopathologically proven prostate adenocarcinoma.
  2. Concern for metastatic disease in the following settings:
  3. Initial staging with intermediate to high risk prostate cancer.
  4. Biochemical recurrence after initial therapy.
  5. Karnofsky performance status of ≥50 (or ECOG/WHO equivalent).
  6. Age > 18.
  7. Ability to understand a written informed consent document, and the willingness to sign it.

You CAN'T join if...

  1. Unable to lie flat, still or tolerate a PET scan.

Location

  • UCSF Imaging Center at China Basin accepting new patients
    San Francisco California 94107 United States

Lead Scientist

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT03803475
Phase
Phase 3
Study Type
Interventional
Last Updated